This tool calculates the 6-month relapse risk for immunocompetent (HIV-negative) visceral leishmaniasis patients who show an initial response to treatment. The tool is based on a prediction model developed from 4,599 patients and 228 relapses recruited into Indian and Nepalese clinical trials between 2000 and 2017.

  • Please only use for immunocompetent patients who show an initial treatment response
  • Please enter patient details that correspond to the timing of initial treatment
  • If no tissue aspirate was performed, please select 'n/a' for parasite count
Range: 0-110 years
Range: 20-180 g/L
Range: 1-1000 days

Risk Assessment Result

--
Enter patient data above to calculate risk percentage
Disclaimer: This tool provides estimated risk based on the input parameters. Always consider the complete clinical picture when making management decisions.